Eli Lilly, Regeneron among first firms chosen for FDA's faster factory-review program
Eli Lilly and Regeneron are among the first seven companies selected for the US Food and Drug Administration's PreCheck Pilot Program, which aims to speed up reviews of new drug-manufacturing facilities. The initiative is designed to encourage more pharmaceutical production on US soil.
CNBC Top News3 h agoLLY REGN